A free weekly email for biotech investors: the coming week’s FDA decision (PDUFA) dates with approval-probability scores, companies that pushed back or dropped a milestone they promised, new stock offerings and last week’s biggest movers. Sent every Sunday before the US market opens.

Get the free weekly biotech catalyst digest Every Sunday: next week’s FDA decision dates with approval odds, missed company milestones, new stock offerings and last week’s big movers. Free, no account needed.
  • Built from FDA, SEC and ClinicalTrials.gov filings, with sources
  • One email a week, unsubscribe in one click

Latest issue

Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Sep 27–Oct 4, 2026) · All past issues

FDA decision dates in your calendar

Put every FDA decision date in your calendar. Subscribe once and new or moved PDUFA dates appear automatically, with approval odds and a link to each company. Free, no account.

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.